More Work Needed To Support Transparency Under Clinical Trials Regulation, Says EFPIA

Research-based drug companies believe the EU guideline on protecting confidential business and personal information in the clinical trials portal CTIS addresses some key concepts, but they point to the need for greater clarity and simplification going forward.